GlassScriptPhysician profile
Gregory P Kaufman
NPI 1417211368
$2,635.20
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,946 · 2020: $150 · 2021: $23.81 · 2022: $168 · 2023: $150 · 2024: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $300 · Food and Beverage: $47.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $300.00 |
| Food and Beverage | $47.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,934.47 | 2019 | |
| Sobi, INC | $150.00 | 2023 | |
| Janssen Scientific Affairs, LLC | $150.00 | 2024 | Talvey |
| Akcea Therapeutics, INC. | $150.00 | 2020 | |
| Legend Biotech USA INC. | $125.10 | 2022 | |
| Stemline Therapeutics INC. | $47.51 | 2024 | Orserdu |
| Mentor Worldwide LLC | $38.56 | 2021-2022 | |
| Glaxosmithkline, LLC. | $28.06 | 2022 | |
| Genentech USA, INC. | $11.50 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.